A New Product Development Partnership Model for Antibiotic Resistance
American Journal of Law & Medicine · 2016-05 · 42 (2-3) · 487-523
DOI: 10.1177/0098858816658277 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Law & Medicine, online erschienen am 06.01.2021. Verfasst von John K Billington. Beteiligte Einrichtung: J.D., M.P.H., Director, U.S. Public Policy, Vaccines at GlaxoSmithKline (GSK). Hauptthemen laut MEDLINE: Drug Discovery, Drug Resistance, Microbial, Public-Private Sector Partnerships. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
Antibiotics have prevented countless deaths from common infections and have made possible many modern medical procedures. Over the past few decades, antibiotic-resistant bacteria have become a global threat, spreading between healthcare facilities and throughout communities worldwide at an alarming pace. Antibiotic overuse and misuse in humans, animals, and the environment accelerate resistance by selecting for bacteria with antibiotic-resistant traits, which then become predominant and infect others. Meanwhile, few antibiotics remain active against the most resistant bacteria. There is an urgent need for new antibiotics and other antibacterial products to replace second-line and last resort therapies when they no longer work. This Article proposes a new U.S.-based, non-governmental, not-for-profit product development partnership (PDP) model specifically designed for antibacterial development. This new model should both supplement and complement existing government-led efforts and should be built with mechanisms in place to balance the values of innovation, access, and conservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- J.D., M.P.H., Director, U.S. Public Policy, Vaccines at GlaxoSmithKline (GSK).
Zitieren
APA
Billington, J. K. (2016). A New Product Development Partnership Model for Antibiotic Resistance. American Journal of Law & Medicine, 42(2-3), 487-523. https://doi.org/10.1177/0098858816658277
Vancouver
Billington JK. A New Product Development Partnership Model for Antibiotic Resistance. American Journal of Law & Medicine. 2016;42(2-3):487-523. doi:10.1177/0098858816658277
BibTeX
@article{Billington2016,
author = {Billington, John K},
title = {A New Product Development Partnership Model for Antibiotic Resistance},
journal = {American Journal of Law & Medicine},
year = {2016},
volume = {42},
number = {2-3},
pages = {487--523},
doi = {10.1177/0098858816658277}
}
EUVIMED